MLYS
MLYS
US6031701013
Mineralys Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.06B EUR
2.38B EUR
2.23B EUR
2.96B EUR
Enterprise Value
1.41B EUR
2.25B EUR
2.12B EUR
2.79B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-9.35x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.75x
4.33x
3.5x
4.58x
EV/Revenue
--
--
--
--
EV/EBITDA
-3.82x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.88%
-5.82%
-6.11%
-3.28%
ende